BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 31244841)

  • 1. Dermatitis Herpetiformis: Novel Perspectives.
    Antiga E; Maglie R; Quintarelli L; Verdelli A; Bonciani D; Bonciolini V; Caproni M
    Front Immunol; 2019; 10():1290. PubMed ID: 31244841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
    Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
    Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.
    Rose C; Armbruster FP; Ruppert J; Igl BW; Zillikens D; Shimanovich I
    J Am Acad Dermatol; 2009 Jul; 61(1):39-43. PubMed ID: 19344979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients.
    Borroni G; Biagi F; Ciocca O; Vassallo C; Carugno A; Cananzi R; Campanella J; Bianchi PI; Brazzelli V; Corazza GR
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):836-41. PubMed ID: 22672004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.
    Reunala T; Salmi TT; Hervonen K
    Acta Derm Venereol; 2015 Nov; 95(8):917-22. PubMed ID: 26059085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Concepts of Dermatitis Herpetiformis.
    Salmi T; Hervonen K
    Acta Derm Venereol; 2020 Feb; 100(5):adv00056. PubMed ID: 32039457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dermatitis herpetiformis].
    Juratli HA; Görög A; Sárdy M
    Hautarzt; 2019 Apr; 70(4):260-264. PubMed ID: 30868254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings.
    Beutner EH; Baughman RD; Austin BM; Plunkett RW; Binder WL
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):329-32. PubMed ID: 10901714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of epidermal transglutaminase by IgA and tissue transglutaminase 2 antibodies in a rare case of Rhesus dermatitis.
    Sestak K; Mazumdar K; Midkiff CC; Dufour J; Borda JT; Alvarez X
    J Vis Exp; 2011 Dec; (58):. PubMed ID: 22214930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue.
    Marietta EV; Camilleri MJ; Castro LA; Krause PK; Pittelkow MR; Murray JA
    J Invest Dermatol; 2008 Feb; 128(2):332-5. PubMed ID: 17762854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis.
    Kumar V; Jarzabek-Chorzelska M; Sulej J; Rajadhyaksha M; Jablonska S
    Clin Immunol; 2001 Mar; 98(3):378-82. PubMed ID: 11237562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatitis herpetiformis.
    Plotnikova N; Miller JL
    Skin Therapy Lett; 2013; 18(3):1-3. PubMed ID: 23674144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of dermatitis herpetiformis.
    Cardones AR; Hall RP
    Immunol Allergy Clin North Am; 2012 May; 32(2):275-81, vi-vii. PubMed ID: 22560140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatitis Herpetiformis: An Update on Diagnosis and Management.
    Reunala T; Hervonen K; Salmi T
    Am J Clin Dermatol; 2021 May; 22(3):329-338. PubMed ID: 33432477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.
    Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.
    Lytton SD; Antiga E; Pfeiffer S; Matthias T; Szaflarska-Poplawska A; Ulaganathan VK; Placek W; Fabbri P; Hall R; Caproni M
    Clin Chim Acta; 2013 Jan; 415():346-9. PubMed ID: 23142793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
    Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatitis herpetiformis.
    Kárpáti S
    Clin Dermatol; 2012; 30(1):56-9. PubMed ID: 22137227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
    Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
    Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease.
    Kaunisto H; Salmi T; Lindfors K; Kemppainen E
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.